Detalles de la búsqueda
1.
Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency.
J Clin Immunol
; 42(3): 512-513, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35174440
Resultados
1 -
1
de 1
1
Próxima >
>>